Caxton Associates (New York)’s Cardiovascular Systems, Inc. CSII Stock Holding History

Caxton Associates (New York)’s Portfolio CSII Stock Details CSII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-19,814	Closed	-$372K	–	762
2021 Q4	$372K	Buy	+19,814	New	+$529K	0.04%	355
2021 Q3	–	Sell	-5,589	Closed	-$238K	–	641
2021 Q2	$238K	Buy	+5,589	New	+$219K	0.03%	379
2019 Q2	–	Sell	-9,462	Closed	-$366K	–	555
2019 Q1	$366K	Buy	+9,462	New	+$321K	0.05%	207
2017 Q2	–	Sell	-8,691	Closed	-$246K	–	592
2017 Q1	$246K	Buy	+8,691	New	+$231K	﹤0.01%	364

Other funds holding CSII

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Caxton Associates (New York)'s CSII Position: Q1 2022 in Review

Caxton Associates (New York) sold out of Cardiovascular Systems, Inc. (CSII) in Q1 2022, closing a stake of 19,814 shares — an estimated $372K sold.

Caxton Associates (New York) first reported a position in CSII in Q1 2017 and held it in 4 quarters. The position peaked at $372K in Q4 2021. 174 funds tracked by Wall St. Rank hold CSII as of Q1 2022.

Caxton Associates (New York) reported no remaining Cardiovascular Systems, Inc. position as of Q1 2022 after selling out during the quarter.
Caxton Associates (New York) sold 19,814 Cardiovascular Systems, Inc. shares in Q1 2022, an estimated $372K.
Caxton Associates (New York) first reported a position in Cardiovascular Systems, Inc. in Q1 2017 and held it in 4 quarters.
Caxton Associates (New York)'s Cardiovascular Systems, Inc. position peaked at $372K in Q4 2021.
174 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q1 2022.

Based on Caxton Associates (New York)'s 13F filing for Q1 2022, filed 16 May 2022.